← Open Payments lookup

CALEY BOGATZ: Open Payments

NPI 1699377515 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,174 in 71 payments from 20 companies in 2025. Trend: 2023 $460 · 2024 $432 · 2025 $1,174

Food & beverage: $1,174
CompanyPaymentsAmount
ABBVIE INC.31$491
PFIZER INC.10$139
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$109
Otsuka America Pharmaceutical, Inc.4$73
Janssen Pharmaceuticals, Inc1$42
Novo Nordisk Inc2$38
Novartis Pharmaceuticals Corporation2$34
Lilly USA, LLC2$33
Lundbeck LLC2$32
Boston Scientific Corporation1$22

Products named: VRAYLAR, UBRELVY, QULIPTA, CAPLYTA, REXULTI, NURTEC ODT, VYNDAMAX, SPRAVATO.

Industry payments across NE — which companies pay providers there.